Fithian’s Bio-Techne TECH Stock Holding History

Fithian’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$7.49M	Buy	101,020 +58,041	+135%	+$4.47M	15.66%	2
2022 Q4	$3.56M	Buy	+42,979	New	+$3.41M	16.93%	2

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fithian's TECH Position: Q1 2023 in Review

Fithian increased its Bio-Techne (TECH) stake by 135% in Q1 2023, buying an estimated $4.47M and bringing the position to 101,020 shares worth $7.49M. The position accounts for 15.66% of the portfolio, ranked #2.

Fithian first reported a position in TECH in Q4 2022 and has held it in 2 quarters since. 550 funds tracked by Wall St. Rank hold TECH as of Q1 2023.

Fithian held 101,020 shares of Bio-Techne worth $7.49M as of Q1 2023.
Fithian bought 58,041 Bio-Techne shares in Q1 2023, an estimated $4.47M.
Bio-Techne made up 15.66% of Fithian's portfolio in Q1 2023, its #2 holding.
Fithian first reported a position in Bio-Techne in Q4 2022 and has held it in 2 quarters since.
550 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2023.

Based on Fithian's 13F filing for Q1 2023, filed 3 May 2023.